Publish date: June 1, 2003
Source:

New York-Eyetech Pharmaceuticals Inc.'s sales force will help sell Pfizer Inc.'s once-daily latanoprost ophthalmic solution (Xalatan) to U.S. ophthalmologists.
The journal page you requested is now available only to registered Modern Medicine members.